Boston Scientific snags BTG for $4.2B

The Federal Trade Commission cleared the merger and the deal is now slated to take effect Aug. 19, Boston Scientific said in an SEC filing Wednesday, a month after it addressed antitrust concerns by divesting its beads business.

By Nick Paul Taylor • Updated Aug. 7, 2019

Colfax strikes $3.15B buyout of orthopaedics player DJO

The acquisition will move the industrial technology conglomerate into a new market: medical devices.

By Nick Paul Taylor • Nov. 20, 2018

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

Boston Scientific to spend over $200M in restructuring

The Marlborough, Massachusetts-based company anticipates "limited" headcount reductions and some employee attrition from a global restructuring plan set to run from 2019 to 2021.

By Susan Kelly • Nov. 19, 2018

Medtronic aneurysm repair device proves durable in complex cases

Three-year registry data showed a high percentage of patients were free from aneurysm-related mortality after receiving the Heli-FX EndoAnchor system.

By Susan Kelly • Nov. 19, 2018

Edwards Lifesciences gets CE mark for advanced heart valve

The company's latest transcatheter aortic valve includes a new delivery system and sheath to help the surgeon place the device in the heart more efficiently and an outer skirt designed to stop leakage.

By Susan Kelly • Nov. 19, 2018

Abbott seeks clearer security standards as feds increase cyber risk focus

President Trump is expected to sign legislation Friday creating a new cyber agency within the Department of Homeland Security. 

By Maria Rachal • Nov. 16, 2018

GE Healthcare recalls nuclear medicine imaging systems

The diagnostic imaging system giant is recalling 996 of the machines after an incident in which a part of the device fell onto the detector below it.

By Susan Kelly • Nov. 16, 2018

With technology foundation solidified, Johnson & Johnson's attention turns to what's next

Though advanced in its technical capabilities, J&J has weighed the merits of build versus buy when it comes technologies like AI.

By Naomi Eide • Nov. 16, 2018

AdvaMed makes lame duck push for medical device tax repeal

Given the impending Democratic control of the House, the trade group's CEO Scott Whitaker said "the chances are not as great next year" for permanent repeal if the industry does not garner a victory.

By David Lim • Nov. 15, 2018

FDA sounds alarm about off-label drug use in pain pumps

The agency wants physicians to stick to approved drugs to reduce the risk of device failure in the pumps, which include those sold by Medtronic and J&J.

By Nick Paul Taylor • Nov. 15, 2018

ResMed wraps up $750M MatrixCare buyout in SaaS push

The sleep apnea company has spent almost $1.7 billion on software businesses in recent years.

By Nick Paul Taylor • Nov. 15, 2018

US Vascular gets FDA warning letter for long-running problems

Most of the points raised in the regulatory notice date back to a 2016 inspection.

By Nick Paul Taylor • Nov. 15, 2018

Millennial to menopausal, women's health is fertile space for startups

Early-stage investors have increased support for female-specific devices and direct-to-consumer diagnostics in the last five years, as the women’s health market is poised to reach $50 billion globally by 2025.

By Maria Rachal • Nov. 14, 2018

Atlantic gains FDA nod for wearable incontinence device

The device delivers electrical stimulation to pelvic floor muscles to prevent the leakage of urine.

By Nick Paul Taylor • Nov. 14, 2018

Medtronic gets CE mark for low-profile thoracic endograft

The clearance comes weeks after FDA approved the Valiant Navion TEVAR endograft.

By Nick Paul Taylor • Nov. 14, 2018

Healthcare will outspend all other industries on R&D by 2020, PwC says

Medtronic is among 23 healthcare companies rated "high-leverage innovators" for its performance on seven key financial indicators. 

By Meg Bryant • Nov. 13, 2018

Cardiva's vascular closure system cuts patient recovery times in study

The findings precede an anticipated FDA decision on a premarket approval application for the company's system for multi-vessel closure.

By Nick Paul Taylor • Nov. 13, 2018

Grassley questions FDA about 'troubling' cybersecurity audit

"Medical devices could be exploited by those same foreign actors to not only interfere with normal device operation, which could cause harm to patients, but also to steal personal medical information," the senator wrote.

By Nick Paul Taylor • Nov. 13, 2018

3D printing poised to disrupt healthcare

Health industry types are "100% convinced, and rightly so, that [3D printing] will be a core part of their business in five to 10 years," ISG's Michael Harmon said.

By Meg Bryant • Nov. 12, 2018

AliveCor's Apple add-on detects afib at similar rate to costly implant

KardiaBand, a wearable electrocardiogram that retails for under $200, spotted 97% of the cardiac events detected by implantable loop recorders​.

By Nick Paul Taylor • Nov. 11, 2018

Owens & Minor names interim chairman and CEO

The leadership shakeup comes against the backdrop of consistently disappointing earnings that have seen the company's shares shed 75% of their value under CEO P. Cody Phipps.

By Susan Kelly • Nov. 9, 2018

Stryker closes $1.4B K2M acquisition

The medical device giant says the deal will augment its own spine and neurotechnology offerings.

By David Lim • Nov. 9, 2018

Monteris modifies brain ablation device to counter safety risk

FDA cleared a new model that features a fiber optic probe designed to stop the original heating problem.

By Nick Paul Taylor • Nov. 9, 2018

Premier to acquire software company Stanson Health for $51.5M

Software-as-a-service provider Stanson's product pipeline includes a tool to give prior authorizations in near real time.

By Meg Bryant • Nov. 8, 2018

Rising Cordis costs drag on Cardinal Health profits

Increased expenditures at the troubled medical device unit stifled profitability.

By Nick Paul Taylor • Nov. 8, 2018